$5.16 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 95 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SYBX | Exit | SYNLOGIC INC | $0 | – | -60,000 | -100.0% | -0.00% | – |
| ADAG | Exit | ADAGENE INCads | $0 | – | -42,722 | -100.0% | -0.01% | – |
| FHTX | Exit | FOGHORN THERAPEUTICS INC | $0 | – | -84,000 | -100.0% | -0.02% | – |
| NAUT | Exit | NAUTILUS BIOTECHNOLOGY INC | $0 | – | -314,835 | -100.0% | -0.03% | – |
| ALITWS | Exit | ALIGHT INC*w exp 05/26/202 | $0 | – | -774,375 | -100.0% | -0.04% | – |
| Exit | VOLTA INC | $0 | – | -300,000 | -100.0% | -0.04% | – | |
| HCAQ | Exit | HEALTHCOR CATALIO ACQU CORP | $0 | – | -300,000 | -100.0% | -0.05% | – |
| FSII | Exit | FS DEVELOPMENT CORP II | $0 | – | -400,000 | -100.0% | -0.07% | – |
| MAAC | Exit | MONTES ARCHIMEDES ACQUISITIO | $0 | – | -500,000 | -100.0% | -0.08% | – |
| NEXI | Exit | NEXIMMUNE INC | $0 | – | -344,223 | -100.0% | -0.09% | – |
| Exit | FRESHWORKS INC | $0 | – | -150,000 | -100.0% | -0.11% | – | |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -963,500 | -100.0% | -0.11% | – |
| Exit | ARCHER AVIATION INC | $0 | – | -750,000 | -100.0% | -0.11% | – | |
| Exit | NERDY INC | $0 | – | -700,000 | -100.0% | -0.12% | – | |
| Exit | EVOLV TECHNOLOGIES HLDNGS IN | $0 | – | -1,367,870 | -100.0% | -0.14% | – | |
| BCAB | Exit | BIOATLA INC | $0 | – | -354,190 | -100.0% | -0.18% | – |
| FSRX | Exit | FINSERV ACQUISITION CORP II | $0 | – | -1,092,600 | -100.0% | -0.18% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -480,480 | -100.0% | -0.19% | – |
| Exit | CAZOO GROUP LTD | $0 | – | -1,509,700 | -100.0% | -0.20% | – | |
| Exit | ROCKET LAB USA INC | $0 | – | -750,000 | -100.0% | -0.20% | – | |
| FREY | Exit | FREYR BATTERY | $0 | – | -2,093,710 | -100.0% | -0.35% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -862,126 | -100.0% | -0.49% | – |
| ESTC | Exit | ELASTIC N V | $0 | – | -271,000 | -100.0% | -0.68% | – |
| NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -256,438 | -100.0% | -0.85% | – |
| MA | Exit | MASTERCARD INCORPORATEDcall | $0 | – | -172,600 | -100.0% | -1.01% | – |
| HWM | Exit | HOWMET AEROSPACE INC | $0 | – | -2,551,230 | -100.0% | -1.34% | – |
| PTON | Exit | PELOTON INTERACTIVE INC | $0 | – | -1,166,800 | -100.0% | -1.71% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -911,226 | -100.0% | -1.92% | – |
| ROST | Exit | ROSS STORES INC | $0 | – | -1,117,935 | -100.0% | -2.05% | – |
| PLAN | Exit | ANAPLAN INC | $0 | – | -2,165,238 | -100.0% | -2.22% | – |
| TWLO | Exit | TWILIO INCcl a | $0 | – | -516,520 | -100.0% | -2.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.